Medical-Device Software Validation and Cybersecurity: Keep Safety and Security in the Same Risk Story

Cybersecurity can become a safety and quality issue

The FDA’s General Principles of Software Validation guidance describes validation principles for medical-device software and software used in quality systems. FDA’s cybersecurity guidance for medical devices addresses cybersecurity considerations and information for premarket submissions. Together, these sources support a practical conclusion: software assurance, security design, and device safety should not be managed as unrelated paperwork streams.

Start with intended use and harms

Define the device function, users, operating environment, data flows, interfaces, update model, and reasonably foreseeable misuse. Identify what could happen if software is unavailable, manipulated, misconfigured, or connected to an untrusted component. Link security threats to device hazards, essential performance, patient impact, and quality-system controls where the relationship exists.

Evidence should cover the lifecycle

1. Requirements for safety, security, performance, access, logging, updates, and recovery.
2. Threat modelling or equivalent analysis appropriate to the device and its environment.
3. Verification and validation of critical functions, interfaces, failure handling, and security controls.
4. Software configuration and version control, including released components and dependencies.
5. Vulnerability intake, assessment, remediation, communication, and update procedures.
6. Post-market monitoring, incident response, and change impact assessment.
7. Records that show decisions, residual risk, test results, deviations, and release approval.

Do not bolt cybersecurity on after validation

A late security review can discover that the architecture cannot support least privilege, secure update, logging, or recovery without changing the intended design. Include security questions in requirements and risk management early. Then test them in the context in which the device will be used, including update and degraded-operation scenarios where relevant.

Keep claims precise

A system can be validated for intended use and still have cybersecurity exposure. A security control can exist and still be ineffective in a particular configuration. State exactly what the evidence demonstrates, what assumptions remain, and how the risk will be monitored. Avoid absolute claims such as “secure” or “compliant” without a defined scope.

VLMS Software helps connect requirements, risks, evidence, change, and approval. Use the applicable device regulations, quality system, and current FDA guidance for the jurisdiction and submission context.